Article citationsMore>>

Allen, M.R., Iwata, K., Phipps, R. and Burr, D.B. (2006) Alterations in Canine Vertebral Bone Turnover, Microdamage Accumulation, and Biomechanical Properties Following 1-Year Treatment with Clinical Treatment Doses of Risedronate or Alendronate. Bone, 39, 872-879.
https://doi.org/10.1016/j.bone.2006.04.028

has been cited by the following article:

• TITLE: Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

  AUTHORS: IsraaIsraa Ahmed Radwan, Nahed Sedky Korany, Bassant Adel Ezzat

  KEYWORDS: Bisphosphonates, Alendronate, Zoledronate, Postmenopausal Osteoporosis

  JOURNAL NAME: Case Reports in Clinical Medicine, Vol.7 No.5, May 10, 2018

  ABSTRACT: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.